Phase I trial of extracellular adenosine 5'-triphosphate in patients with advanced cancer

Medical and Pediatric Oncology

Volumn 27, Issue 3, 1996, Pages 165-173

  Haskell, Charles M ^a,b,c,d   Wong, Maylene ^a,b   Williams, Adrian ^a,b   Lee, Le Young ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROSS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

biomodulation; drug resistance; nonsmall cell lung cancer; pharmacokinetics

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE S PHASE; CELL DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DYSPNEA; FEMALE; FEVER; HEADACHE; HEART FUNCTION; HUMAN; HYPOTENSION; HYPOXIA; LUNG NON SMALL CELL CANCER; MALE; MEMBRANE PERMEABILITY; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; THORAX PAIN; VERTIGO; VOMITING;

ADENOSINE TRIPHOSPHATE; AGED; ANTINEOPLASTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASMS; RESPIRATORY MECHANICS; STROKE VOLUME;

EID: 0029808218     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199609)27:3<165::AID-MPO6>3.0.CO;2-C     Document Type: Article

References (21)

1. Rapaport E: Treatment of human tumor cells with ADP and ATP yields arrest of growth in the S phase of the cell cycle. J Cell Physiol 114:279-283, 1983.
2. Rapaport E: Experimental cancer therapy in mice by adenine nucleotides. Eur J Cancer Clin Oncol 24:1491-1497, 1988.
3. Beyer EC, Steinberg TH: Evidence that the gap junction protein connexin-43 is the ATP-induced pore of mouse macrophages. J Biol Chem 266:7971-7974, 1991.
4. Lowenstein WR: The cell to cell channel of gap junctions. Cell 48:725-726, 1987.
5. Vandewalle B, Hornez L, Revillion F, Lefebvre J: Effect of extracellular ATP on breast tumor cell growth, implication of intracellular calcium. Cancer Lett 85:47-54, 1994.
6. Zheng LM, Zychlinsky A, Liu C-C, Ojcius DM, Ding E, Young J: Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol 112:279-288, 1991.
7. Spranzi E, Djeu JY, Hoffman SL, Epling-Burnette PK, Blanchard DK: Lysis of human monocytic leukemia cells by extracellular adenosine triphosphate: Mechanism and characterization of the adenosine triphosphate receptor. Blood 82:1578-1585, 1993.
8. Di Virgilio F, Pizzo P, Zanovello P, Bronte V, Collavo D: Extracellular ATP as a possible mediator of cell-mediated cytotoxicity. Immunol Today 11:274-2877, 1990.
9. Avery RK, Bleier KJ, Pasternack MS: Differences between ATP-mediated cytotoxicity and cell-mediated cytotoxicity. J Immunol 149:1265-1270, 1992.
10. Rapaport E, Fontaine J: Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools. Proc Natl Acad Sci USA 86:1662-1666, 1989.
11. Lasso de la Vega MC, Terradez P, Obrador E, Navarro J, Pellicer JA, Estrela JM: Inhibition of cancer growth and selective glutathione depletion in Ehrlich tumour cells in vivo by extracellular ATP. Biochem J 298:99-105, 1994.
12. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceci RJ, Kramer R, Guidotti G, Cantiello HF: The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci USA 90:312-316, 1993.
13. Maymon R, Maymon BBS, Cohenarmon M, Holtzinger M, Leibovici J: Enhancing effect of ATP on intracellular Adriamycin penetration in human ovarian cancer cell lines. Biochem Biophys Acta 1201:173-178, 1994.
14. Fukunaga AF, Sodeyama O, Matsuzaki Y, Ideda K, Matsuda I, Sato K: Hemodynamic and metabolic changes of ATP-induced hypotension during surgery. Anesthesiology 59:A12, 1983.
15. Gaba SJM, Préfaut C: Comparison of pulmonary and systemic effects of adenosine triphosphate in chronic obstructive pulmonary disease -ATP: A pulmonary controlled vasoregulator? Eur Respir J 3:450-455, 1990.
16. Flack WE: Adenosine and adenosine triphosphate for acute blood pressure control. Semin Anesthesia 7:216-225, 1988.
17. Beutler F, Baluda MC: Simplified determination of blood ATP using the Firefly system. Blood 23:688-698, 1964.
18. Ganz PA, Haskell CM, Figlin RA, La Soto N, Siau J, for the UCLA Solid Tumor Study Group: Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the functional living index-cancer. Cancer 61:849-856, 1988.
19. Loprinzi CL, Laurie JA, Wieand HS, Krook JE, Novotny PJ, Kugler JW, Bartel J, Law M, Bateman M, Klatt NE, Dose AM, Etzell PS, Nelimark RA, Mailliard JA, Moertel CG, for the North Central Cancer Treatment Group: Prospective evaluation of prognostic variables from patient-completed questionnaires. J Clin Oncol 12:601-607, 1994.
20. Adenosine. In Halperin JA, Grady LT, Johnson KW, Allen Jr LV, Allison JR, Ambrosio TJ, et al. (eds): "USP DI. Volume I, Drug Information for the Health Care Professional." 14th ed. Rockville, MD: U.S. Pharmacopoeia, Drug Information Division, 1994, pp. 28-30.
21. Fossella FV, Lee JS, Murphy WK, Lippman SM, Calayag M, Pang A, Chasen M, Shin DM, Glisson B, Benner S, Huber M, Perez-Soler R, Hong WK, Raber M: Phase II study of docetaxel for recurrent or metastatic non-small cell lung cancer. J Clin Oncol 12:1238-1244, 1994.